{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:32:40Z","timestamp":1780450360909,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11906-014-0419-y","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T06:05:43Z","timestamp":1390889143000},"source":"Crossref","is-referenced-by-count":7,"title":["The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension"],"prefix":"10.1007","volume":"16","author":[{"given":"James Brian","family":"Byrd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Jamerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"419_CR1","doi-asserted-by":"crossref","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417\u201328.","DOI":"10.1056\/NEJMoa0806182"},{"issue":"6","key":"419_CR2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chabanian","year":"2003","unstructured":"Chabanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"2","key":"419_CR3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2011.05.010","volume":"162","author":"JB Byrd","year":"2011","unstructured":"Byrd JB, Zeng C, Tavel HM, Magid DJ, O'Connor PJ, Margolis KL, et al. Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J. 2011;162(2):340\u20136. A longitudinal study of combination anti-hypertensive medication prescribing practices and blood pressure outcomes in a large population.","journal-title":"Am Heart J"},{"issue":"3","key":"419_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","volume":"47","author":"EC Okonofua","year":"2006","unstructured":"Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345\u201351.","journal-title":"Hypertension"},{"key":"419_CR5","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"issue":"5","key":"419_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11606-008-0544-x","volume":"23","author":"F Pan","year":"2008","unstructured":"Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med. 2008;23(5):611\u20134.","journal-title":"J Gen Intern Med"},{"key":"419_CR7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","volume":"375","author":"GL Bakris","year":"2010","unstructured":"Bakris GL, Sarafidis PA, Weir MR, Dahlof B, Pitt B, Jamerson K, et al. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial. Lancet. 2010;375:1173\u201381.","journal-title":"Lancet"},{"key":"419_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(12)61343-9","volume":"381","author":"MA Weber","year":"2013","unstructured":"Weber MA, Jamerson K, Bakris GL, Weir MR, Zappe D, Zhang Y, et al. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomized controlled trial. Lancet. 2013;381:537\u201345.","journal-title":"Lancet"},{"key":"419_CR9","doi-asserted-by":"crossref","unstructured":"James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;2013.","DOI":"10.1001\/jama.2013.284427"},{"key":"419_CR10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981\u201397.","journal-title":"JAMA"},{"key":"419_CR11","doi-asserted-by":"crossref","unstructured":"Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Clin Hypertens. 2011;13(3):146\u201354. This document provides a detailed discussion of many aspects of combination therapy in hypertension.","DOI":"10.1111\/j.1751-7176.2010.00397.x"},{"key":"419_CR12","doi-asserted-by":"crossref","unstructured":"The Taskforce for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH\/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281\u20131357. These guidelines discuss the ACCOMPLISH trial results and their implications for practice.","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"419_CR13","unstructured":"National Institute for Health and Care Excellence (NICE) Clinical Guidelines. Hypertension: clinical management of primary hypertension in adults. NICE Clinical Guideline 127. 2011; www.nice.org.uk\/guidance\/CG127 ."},{"key":"419_CR14","doi-asserted-by":"crossref","unstructured":"Jamerson KA, Devereux R, Bakris GL, Dahlof B, Pitt B, Velazquez EJ et al. Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control. Hypertension. 2011;57:174\u20139. This study suggests that the superior outcomes in the amlodipine-benazepril arm of ACCOMPLISH cannot be attributed to excess blood pressure-lowering in that arm compared to the amlodipine-hydrochlorothiazide arm.","DOI":"10.1161\/HYPERTENSIONAHA.110.159939"},{"key":"419_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1056\/NEJMc1001410","volume":"363","author":"KA Jamerson","year":"2010","unstructured":"Jamerson KA, Bakris GL, Weber MA. 24-hour ambulatory blood pressure in the ACCOMPLISH trial. N Engl J Med. 2010;363:98.","journal-title":"N Engl J Med"},{"key":"419_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","volume":"46","author":"E Dolan","year":"2005","unstructured":"Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156\u201361.","journal-title":"Hypertension"},{"key":"419_CR17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","volume":"43","author":"BL Carter","year":"2004","unstructured":"Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension. 2004;43:4\u20139.","journal-title":"Hypertension"},{"key":"419_CR18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0002-8703(89)90834-X","volume":"118","author":"DR Abernathy","year":"1989","unstructured":"Abernathy DR. The pharmacokinetic profile of amlodipine. Am Heart J. 1989;118:1100\u20133.","journal-title":"Am Heart J"},{"key":"419_CR19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","volume":"47","author":"ME Ernst","year":"2006","unstructured":"Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJG, Bryles Phillips B, Zimmerman MB, et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension. 2006;47:352\u20138.","journal-title":"Hypertension"},{"issue":"20","key":"419_CR20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/eurheartj\/ehr177","volume":"32","author":"PS Sever","year":"2011","unstructured":"Sever PS, Messerli FH. Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011;32(20):2499\u2013506.","journal-title":"Eur Heart J"},{"key":"419_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.163.5.525","volume":"63","author":"JG Douglas","year":"2003","unstructured":"Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, et al. Management of high blood pressure in African Americas. Consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;63:525\u201341.","journal-title":"Arch Intern Med"},{"key":"419_CR22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.110.152892","volume":"56","author":"JM Flack","year":"2010","unstructured":"Flack JM, Sica DA, Bakris G, Brown A, Ferdinand KC, Grimm Jr RH, et al. Management of high blood pressure in African Americans: an update of the ISHIB consensus statement. Hypertension. 2010;56:780\u2013800.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-014-0419-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-014-0419-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-014-0419-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T02:55:16Z","timestamp":1688957716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-014-0419-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s11906-014-0419-y","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]},"article-number":"419"}}